14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 26 Apr 2024

Trading levels for BTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.98 5.59 %
R2 0.96 2.72 %
R1 0.94 0.95 %
Current price: 0.93
Support S1 0.89 -4.79 %
S2 0.87 -6.57 %
S3 0.84 -9.44 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.05 12.67 %
R2 0.98 5.16 %
R1 0.94 0.665 %
Current price 0.93
Support S1 0.92 -1.81%
S2 0.90 -3.42%
S3 0.790 -15.23%

BTX Predictions History

4 years ago
JS predicted that BTX for 2019-05-07 is going $1.27 (2.42%)

4 years ago
Alex.TinyVillianaire.Goh.110165 predicted that BTX for 2019-05-07 is going $1.18 (-4.84%)

Rank:

4 years ago
NameNotImportant predicted that BTX for 2019-05-03 is going $1.29 (2.38%)

4 years ago
PumpTheseNumbers predicted that BTX for 2019-04-30 is going $1.33 (7.26%)

4 years ago
Zachary predicted that BTX for 2019-04-30 is going $1.60 (29.03%)

Rank:

4 years ago
Profit.Prophet.108044 predicted that BTX for 2019-04-30 is going $1.33 (7.26%)

5 years ago
PumpTheseNumbers predicted that BTX for 2019-04-25 is going $1.28 (4.07%)

5 years ago
JS predicted that BTX for 2019-04-25 is going $1.24 (0.81%)

5 years ago
JS predicted that BTX for 2019-04-24 is going $1.29 (3.20%)

5 years ago
NameNotImportant predicted that BTX for 2019-04-24 is going $1.18 (-6.35%)

Click to get the best stock tips daily for free!

About BioTime, Inc

BioTime Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics,... BTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT